Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection.
Lawitz E, Flisiak R, Abunimeh M, Sise ME, Park JY, Kaskas M, Bruchfeld A, Wörns MA, Aglitti A, Zamor PJ, Xue Z, Schnell G, Jalundhwala YJ, Porcalla A, Mensa FJ, Persico M.
Lawitz E, et al. Among authors: zamor pj.
Liver Int. 2020 May;40(5):1032-1041. doi: 10.1111/liv.14320. Epub 2019 Dec 26.
Liver Int. 2020.
PMID: 31821716
Clinical Trial.